Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moshe Talpaz

Showing results (251-260 of 264) with videos related to

Pageof 27
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|September 4, 2020
Myeloid/Lymphoid Neoplasms with Eosinophilia and TK Fusion Genes, Version 3.2021, NCCN Clinical Practice Guidelines in OncologyAaron T Gerds, Jason Gotlib, Prithviraj Bose, et al.
JAMA Oncology|February 25, 2021
Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid TumorsErin F Cobain, Yi-Mi Wu, Pankaj Vats, et al.
Oncotarget|November 23, 2017
Rapid, ultra low coverage copy number profiling of cell-free DNA as a precision oncology screening strategyDaniel H Hovelson, Chia-Jen Liu, Yugang Wang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 23, 2024
Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in OncologyNeil P Shah, Ravi Bhatia, Jessica K Altman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2023
A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with MyelofibrosisJohn Mascarenhas, Anna Rita Migliaccio, Heidi Kosiorek, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 11, 2024
NCCN Guidelines® Insights: Systemic Mastocytosis, Version 3.2024Jason Gotlib, Aaron T Gerds, Peter Abdelmessieh, et al.
The New England Journal of Medicine|December 12, 2019
Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor FailureTimothy P Hughes, Michael J Mauro, Jorge E Cortes, et al.
Blood|May 3, 2002
Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II studyCharles L Sawyers, Andreas Hochhaus, Eric Feldman, et al.
Nature|August 8, 2017
Integrative clinical genomics of metastatic cancerDan R Robinson, Yi-Mi Wu, Robert J Lonigro, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 9, 2026
NCCN Guidelines® Insights: Myeloproliferative Neoplasms, Version 2.2026Aaron T Gerds, Jason Gotlib, Peter Abdelmessieh, et al.
Pageof 27

Showing results (251-260 of 264) with videos related to

Sort By:
Pageof 27
Journal of the National Comprehensive Cancer Network : JNCCN|September 4, 2020
Myeloid/Lymphoid Neoplasms with Eosinophilia and TK Fusion Genes, Version 3.2021, NCCN Clinical Practice Guidelines in OncologyAaron T Gerds, Jason Gotlib, Prithviraj Bose, et al.
JAMA Oncology|February 25, 2021
Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid TumorsErin F Cobain, Yi-Mi Wu, Pankaj Vats, et al.
Oncotarget|November 23, 2017
Rapid, ultra low coverage copy number profiling of cell-free DNA as a precision oncology screening strategyDaniel H Hovelson, Chia-Jen Liu, Yugang Wang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 23, 2024
Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in OncologyNeil P Shah, Ravi Bhatia, Jessica K Altman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2023
A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with MyelofibrosisJohn Mascarenhas, Anna Rita Migliaccio, Heidi Kosiorek, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 11, 2024
NCCN Guidelines® Insights: Systemic Mastocytosis, Version 3.2024Jason Gotlib, Aaron T Gerds, Peter Abdelmessieh, et al.
The New England Journal of Medicine|December 12, 2019
Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor FailureTimothy P Hughes, Michael J Mauro, Jorge E Cortes, et al.
Blood|May 3, 2002
Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II studyCharles L Sawyers, Andreas Hochhaus, Eric Feldman, et al.
Nature|August 8, 2017
Integrative clinical genomics of metastatic cancerDan R Robinson, Yi-Mi Wu, Robert J Lonigro, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 9, 2026
NCCN Guidelines® Insights: Myeloproliferative Neoplasms, Version 2.2026Aaron T Gerds, Jason Gotlib, Peter Abdelmessieh, et al.
Pageof 27